Augmedix Balance Sheet Health
Financial Health criteria checks 5/6
Augmedix has a total shareholder equity of $17.8M and total debt of $20.5M, which brings its debt-to-equity ratio to 115%. Its total assets and total liabilities are $59.6M and $41.8M respectively.
Key information
115.0%
Debt to equity ratio
US$20.45m
Debt
Interest coverage ratio | n/a |
Cash | US$37.30m |
Equity | US$17.78m |
Total liabilities | US$41.78m |
Total assets | US$59.56m |
Recent financial health updates
Recent updates
Is Augmedix, Inc. (NASDAQ:AUGX) Trading At A 40% Discount?
May 21Augmedix, Inc. (NASDAQ:AUGX) Shares Slammed 29% But Getting In Cheap Might Be Difficult Regardless
Apr 25Augmedix: Secular AI Tailwinds, But Still Unattractive Risk-Reward
Mar 24Augmedix, Inc. (NASDAQ:AUGX) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates
Nov 09Augmedix reports Q2 results
Aug 08Augmedix: A Splendid Long-Term Investing Opportunity
Jan 21Financial Position Analysis
Short Term Liabilities: AUGX's short term assets ($50.0M) exceed its short term liabilities ($24.5M).
Long Term Liabilities: AUGX's short term assets ($50.0M) exceed its long term liabilities ($17.3M).
Debt to Equity History and Analysis
Debt Level: AUGX has more cash than its total debt.
Reducing Debt: AUGX had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: AUGX has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if AUGX has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.